
Chemical and Pharmaceutical Bulletin p. 946 - 950 (1993)
Update date:2022-08-03
Topics:
Iwata
Maezaki
Hattori
Fujita
Moritani
Takemoto
Tanaka
Imanishi
The total synthesis of (+)-talaromycin A and (-)-talaromycin B was accomplished by utilizing a common intermediate (3). The spiroketal (3) was converted to the olefin (4) via thermolysis of the sulfinyl group, C1-unit elongation at the C9-position, and isomerization at the spiro center. On the other hand, 3 was isomerized to 7 at the C9-position and then converted to the olefin (5) in a similar manner to that described for (+)-talaromycin A. These intermediates (4 and 5) were transformed into (+)-talaromycin A and (-)-talaromycin B via addition reaction of trifluoroacetic acid and oxymercuration, respectively.
View MoreContact:+86-310-7092106
Address:Quzhou Modern & New Industrial Park, Handan, Hebei 057250, China
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
qingdao goldenchem imp and exp co.,ltd.
Contact:532-55579246
Address:no.62 ,haier road laoshan distirct
Zhejiang Haizhou Pharmaceutical Co., Ltd.
website:https://www.haizhoupharma.com/
Contact:+86-576-88221016
Address:No. 19, Donghai 5th Avenue, Yanhai Industrial Zone, Linhai, Zhejiang, China
Xiamen Goodhealth Pharmchem Co., Ltd.
Contact:0086-592-2097683
Address:404R No.2 54# Minzu Rd., Xiamen, China
Doi:10.1002/anie.200803538
(2009)Doi:10.1039/c4cy01157k
(2015)Doi:10.1021/jm400556w
(2013)Doi:10.1002/adsc.201501130
(2016)Doi:10.1016/j.cclet.2016.12.034
(2017)Doi:10.1021/jo802709q
(2009)